ENG
KOR
PTF
ICPI WEEKFrequently Asked Questions (FAQ)
- Date2025.12.17
- Hit181
| Inquiries about the 2026 EMPA Annual Meeting & Expo | |
| Ⅰ. About EMPA & the Operating Organization | |
| Q1. What is the Emerging Markets Pharma Alliance (EMPA)? | EMPA is a global alliance comprised mainly of pharmaceutical manufacturers with annual revenue of KRW 150 billion or less. Under the core theme, “Sharing and Collaboration for the Future of the Pharmaceutical Industry,” the alliance promotes practical cooperation among emerging-market pharmaceutical companies through B2B networking, CMO, GMP, and rotational workforce training programs. |
| Q2. What is the Pharmaceutical Technology Foundation, the organization operating EMPA? | The Pharmaceutical Technology Foundation is a non-profit foundation established through the integration of the GMP Academy, which has operated pharmaceutical technology seminars since 2004, and the GMP Association, which administers GMP professional certification programs. Its primary mission is global GMP networking in the pharmaceutical sector, and it is an organization approved by Korea’s Ministry of Food and Drug Safety (MFDS). |
| Ⅱ. Membership Scope & Eligibility | |
| Q3. Who does “Emerging Markets Pharma” refer to in EMPA? | It does not refer only to pharmaceutical companies in developing countries. It includes all mid-sized pharmaceutical manufacturers worldwide with annual revenue of KRW 150 billion or less, excluding multinational corporations and large enterprises. |
| Q4. What are the eligibility requirements for EMPA membership? | Any pharmaceutical company with a manufacturing license and annual revenue of KRW 150 billion or less will be automatically registered as a member upon submitting the participation application form on the official website. |
| Q5. Is there a membership fee or annual dues? | No. EMPA is an open platform with no membership fee or annual dues. |
| Ⅲ. Overview of the Annual Meeting | |
| Q6. What is EMPA’s “Annual Meeting”? | This is an annual general meeting where participating pharmaceutical companies share information on products, dosage forms, contract manufacturing (CMO), clinical activities, and regulatory/registration topics, with the primary purpose of business networking. |
| Q7. What are the event dates and venue? | Pharma & Bio Expo: March 31 (Tue) – April 3 (Fri), 2026, at KINTEX Exhibition Hall. EMPA Annual Meeting: April 1 (Wed) – April 2 (Thu), 2026, at the KINTEX seminar rooms and the Gloucester Hotel. |
| Q8. How many participants will attend in total? | Participation is limited to 80 companies (40 domestic and 40 overseas), and the total number of participants is restricted to approximately 100 people. |
| Ⅳ. Participation Conditions & Limits | |
| Q9. Is there a limit on the number of participants per company? | Up to two participants are allowed per company, and one hotel room is provided per company. If two participants attend, they may share one room or request an additional room for a fee (USD 100). |
| Q10. Are there any eligibility requirements for individual participants? | As this event is intended for business meetings, there is an evaluation period of up to seven days after application submission. Key executives such as CEOs, plant managers, and R&D directors will be prioritized for approval. |
| Ⅴ. Benefits & Costs | |
| Q11. What benefits are provided to participating member companies? | Overseas companies: 2 nights / 3 days hotel accommodation, breakfast, official dinner banquet, Annual Meeting sessions, seminars, and Expo access. Domestic companies: 1 night / 2 days hotel accommodation, breakfast, official dinner banquet, Annual Meeting sessions, seminars, and Expo access. All benefits are provided free of charge. |
| Q12. Are airfare or transportation expenses covered? | No. Airfare and transportation expenses are not covered. |
| Q13. Can domestic companies participate without hotel accommodation? | Yes. Participation is available regardless of whether hotel accommodation is used. |
| Ⅵ. Program & Operations | |
| Q14. How will B2B / Member-to-Member (M2M) meetings be conducted? | After registration is completed, each manufacturer’s shareable information (products, dosage forms, CMO capabilities, etc.) will be coded and shared only with participating companies. Meetings will be facilitated through assigned seating and pre-categorization. |
| Q15. Will there be opportunities for company presentations or promotion? | Yes. A major part of the Annual Meeting program is dedicated to company presentations and the sharing/promotion of products, dosage forms, and CMO collaboration opportunities. |
| Q16. What languages will be used during the event? | The event will be conducted in Korean and English. For third languages, participants are encouraged to use translation applications; therefore, bringing a laptop or tablet is recommended. |
| Ⅶ. Mandatory Attendance & Other Notes | |
| Q17. Is attendance at both the Annual Meeting and Expo mandatory? | The complimentary benefits are provided on the premise of attending the Annual Meeting. Attendance is mandatory on April 1 (Wed) 14:00–21:00 and April 2 (Thu) 10:00–12:00. Attendance will be monitored during the meeting. If a participant is absent without valid reason, costs may be charged and additional measures may apply. |
| Q18. Will an invitation letter be provided for visa processing? | Upon request from an overseas company, an invitation letter will be issued under the name of the Pharmaceutical Technology Foundation after the application evaluation is completed. |
| Q19. What if a multinational company or large enterprise applies? | They may apply; however, if approved, they will participate as non-members and a participation fee of USD 1,200 will apply. |
| Q20. Can GMP manufacturers of medical devices, cosmetics, or health functional foods apply? | They may apply; however, in the evaluation process they will be reviewed with lower priority than pharmaceutical GMP manufacturers. |
| Ⅷ. Application Process | |
| Q21. What does “first-come, first-served” mean? | It means that applications will close once the total participant limit (approximately 100 people) is exceeded. |
| Q22. How long does it take from application submission to approval? | Approval decisions will be made within seven days after submission of the application form. |
Apply 
My Registration